{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:32:50Z","timestamp":1793730770726,"version":"4.6.1"},"reference-count":55,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVE:<\/jats:title>\n                  <jats:p>Subcutaneous immunotherapy (SCIT) is approved in the United States for the treatment of pediatric asthma and rhinitis; sublingual immunotherapy (SLIT) does not have regulatory approval but is used in clinical practice. The objective of this study was to systematically review the evidence regarding the efficacy and safety of SCIT and SLIT for the treatment of pediatric asthma and allergic rhinoconjunctivitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>Two independent reviewers selected articles for inclusion, extracted data, and graded the strength of evidence for each clinical outcome. All studies were randomized controlled trials of children with allergic asthma or rhinoconjunctivitis treated with SCIT or an aqueous formulation of SLIT. Data sources were Medline, Embase, LILACS, CENTRAL, and the Cochrane Central Register of Controlled Trials through May 2012.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>In 13 trials, 920 children received SCIT or usual care; in 18 studies, 1583 children received SLIT or usual care. Three studies compared SCIT with SLIT head-to-head in 135 children. The strength of evidence is moderate that SCIT improves asthma and rhinitis symptoms and low that SCIT improves conjunctivitis symptoms and asthma medication scores. Strength of evidence is high that SLIT improves asthma symptoms and moderate that SLIT improves rhinitis and conjunctivitis symptoms and decreases medication usage. The evidence is low to support SCIT over SLIT for improving asthma or rhinitis symptoms or medication usage. Local reactions were frequent with SCIT and SLIT. There was 1 report of anaphylaxis with SCIT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>Evidence supports the efficacy of both SCIT and SLIT for the treatment of asthma and rhinitis in children.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2013-0343","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T01:43:41Z","timestamp":1367891021000},"page":"1155-1167","source":"Crossref","is-referenced-by-count":142,"title":["Allergen-Specific Immunotherapy for Pediatric Asthma and Rhinoconjunctivitis: A Systematic Review"],"prefix":"10.1542","volume":"131","author":[{"given":"Julia M.","family":"Kim","sequence":"first","affiliation":[{"name":"Departments of Pediatrics, Division of General Pediatrics and Adolescent Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Y.","family":"Lin","sequence":"additional","affiliation":[{"name":"Otolaryngology-Head and Neck Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Suarez-Cuervo","sequence":"additional","affiliation":[{"name":"Medicine, Division of General Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohalakshmi","family":"Chelladurai","sequence":"additional","affiliation":[{"name":"Medicine, Division of General Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murugappan","family":"Ramanathan","sequence":"additional","affiliation":[{"name":"Otolaryngology-Head and Neck Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi B.","family":"Segal","sequence":"additional","affiliation":[{"name":"Medicine, Division of General Internal Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkiruka","family":"Erekosima","sequence":"additional","affiliation":[{"name":"Medicine, Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2013,6,1]]},"reference":[{"key":"2021120900375587400_B1","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma\u2014summary report 2007.","volume":"120","author":"National Asthma Education and Prevention Program","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2021120900375587400_B2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter.","volume":"122","author":"Wallace","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"2021120900375587400_B3"},{"key":"2021120900375587400_B4"},{"issue":"5","key":"2021120900375587400_B5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jclinepi.2009.03.009","article-title":"AHRQ series paper 5: grading the strength of a body of evidence when comparing medical interventions\u2014Agency for Healthcare Research and Quality and the effective health-care program.","volume":"63","author":"Owens","year":"2010","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"2021120900375587400_B6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0091-6749(05)80058-2","article-title":"Evolution of the late asthmatic reaction during immunotherapy and after stopping immunotherapy.","volume":"86","author":"Van Bever","year":"1990","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2021120900375587400_B7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000161585","article-title":"Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy.","volume":"148","author":"Schubert","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"issue":"4","key":"2021120900375587400_B8","first-page":"213","article-title":"Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy.","volume":"28","author":"Akmanlar","year":"2000","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"4","key":"2021120900375587400_B9","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0091-6749(99)70232-0","article-title":"Immunotherapy in children with allergic asthma: effect on bronchial hyperreactivity and pharmacotherapy.","volume":"103","author":"Hedlin","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"2021120900375587400_B10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1399-3038.2011.01196.x","article-title":"Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: a randomized controlled study.","volume":"22","author":"Pajno","year":"2011","journal-title":"Pediatr Allergy Immunol"},{"issue":"6312","key":"2021120900375587400_B11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/bmj.284.6312.306","article-title":"Failure of hyposensitisation in treatment of children with grass-pollen asthma.","volume":"284","author":"Hill","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"6","key":"2021120900375587400_B12","first-page":"309","article-title":"Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.","volume":"27","author":"Altinta\u015f","year":"1999","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"9","key":"2021120900375587400_B13","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1034\/j.1398-9995.2002.23498.x","article-title":"Benefits of immunotherapy with a standardized Dermatophagoides pteronyssinus extract in asthmatic children: a three-year prospective study.","volume":"57","author":"Pifferi","year":"2002","journal-title":"Allergy"},{"issue":"3","key":"2021120900375587400_B14","first-page":"173","article-title":"Immunotherapy in allergy to dog. Immunologic and clinical findings of a double-blind study.","volume":"57","author":"Valovirta","year":"1986","journal-title":"Ann Allergy"},{"issue":"5","key":"2021120900375587400_B15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1056\/NEJM199701303360502","article-title":"A controlled trial of immunotherapy for asthma in allergic children.","volume":"336","author":"Adkinson","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"2021120900375587400_B16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mai.2002.121317","article-title":"Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).","volume":"109","author":"M\u00f6ller","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2021120900375587400_B17","first-page":"90","article-title":"A three-year prospective study of specific immunotherapy to inhalant allergens: evidence of safety and efficacy in 300 children with allergic asthma.","volume":"7","author":"Cantani","year":"1997","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"2","key":"2021120900375587400_B18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1398-9995.1986.tb00289.x","article-title":"A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results.","volume":"41","author":"Dreborg","year":"1986","journal-title":"Allergy"},{"key":"2021120900375587400_B19","doi-asserted-by":"crossref","unstructured":"Kuna P, Kaczmarek J, Kupczyk M. Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children. J Allergy Clin Immunol. 2011;127(2):502\u2013508.e1\u20136","DOI":"10.1016\/j.jaci.2010.11.036"},{"issue":"7","key":"2021120900375587400_B20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1398-9995.2006.01068.x","article-title":"Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.","volume":"61","author":"Niggemann","year":"2006","journal-title":"Allergy"},{"issue":"8","key":"2021120900375587400_B21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study.","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"issue":"9","key":"2021120900375587400_B22","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1034\/j.1398-9995.2000.00495.x","article-title":"Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study.","volume":"55","author":"Pajno","year":"2000","journal-title":"Allergy"},{"issue":"6","key":"2021120900375587400_B23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1399-3038.2006.00443.x","article-title":"Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.","volume":"17","author":"Lue","year":"2006","journal-title":"Pediatr Allergy Immunol"},{"issue":"8","key":"2021120900375587400_B24","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.rmed.2005.11.016","article-title":"Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.","volume":"100","author":"Niu","year":"2006","journal-title":"Respir Med"},{"key":"2021120900375587400_B25","doi-asserted-by":"crossref","DOI":"10.1111\/j.1399-3038.2011.01219.x","article-title":"Sublingual immunotherapy not effective in house dust mite-allergic children in primary care.","author":"de Bot","year":"2012","journal-title":"Pediatr Allergy Immunol"},{"issue":"2\u20133","key":"2021120900375587400_B26","first-page":"105","article-title":"Changes in serum specific IgG4 and IgG4\/IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial.","volume":"26","author":"Tseng","year":"2008","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"2 pt 1","key":"2021120900375587400_B27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0091-6749(99)70388-X","article-title":"Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis.","volume":"104","author":"La Rosa","year":"1999","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2021120900375587400_B28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaci.2004.07.012","article-title":"Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.","volume":"114","author":"Novembre","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"2021120900375587400_B29","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaci.2006.12.651","article-title":"Sublingual immunotherapy with grass pollen is not effective in symptomatic youngsters in primary care.","volume":"119","author":"R\u00f6der","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"2021120900375587400_B30"},{"issue":"2","key":"2021120900375587400_B31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S1081-1206(10)60211-6","article-title":"Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study.","volume":"101","author":"Marogna","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"2021120900375587400_B32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-3038.1997.tb00138.x","article-title":"Double-blind placebo-controlled study of sublingual immunotherapy with house dust mite extract (D.pt.) in children.","volume":"8","author":"Hirsch","year":"1997","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"2021120900375587400_B33","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ppul.1088","article-title":"Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.","volume":"32","author":"Bah\u00e7eciler","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"2021120900375587400_B34","first-page":"277","article-title":"Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double-blind study.","volume":"18","author":"Tari","year":"1990","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"12","key":"2021120900375587400_B35","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1111\/j.1365-2222.2003.01809.x","article-title":"Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate.","volume":"33","author":"Pajno","year":"2003","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"2021120900375587400_B36","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1398-9995.1998.tb03952.x","article-title":"Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization.","volume":"53","author":"Vourdas","year":"1998","journal-title":"Allergy"},{"issue":"10","key":"2021120900375587400_B37","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1398-9995.2006.01190.x","article-title":"Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.","volume":"61","author":"Valovirta","year":"2006","journal-title":"Allergy"},{"issue":"3","key":"2021120900375587400_B38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1034\/j.1399-3038.2003.00025.x","article-title":"Immunomodulation during sublingual therapy in allergic children.","volume":"14","author":"Ippoliti","year":"2003","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"2021120900375587400_B39","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000327566","article-title":"Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.","volume":"157","author":"Yukselen","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"2021120900375587400_B40","article-title":"Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic\/rhinitis children sensitized to house dust mite: an open randomized controlled study.","volume":";40(6):922\u2013932.","author":"Eifan","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"2021120900375587400_B41"},{"issue":"1","key":"2021120900375587400_B42","first-page":"CD001936","article-title":"Allergen injection immunotherapy for seasonal allergic rhinitis.","author":"Calderon","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"2021120900375587400_B43","first-page":"CD001186","article-title":"Injection allergen immunotherapy for asthma.","author":"Abramson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2021120900375587400_B44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-3038.2007.00648.x","article-title":"Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review.","volume":"19","author":"R\u00f6der","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"2021120900375587400_B45","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1378\/chest.06-1425","article-title":"Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age.","volume":"133","author":"Penagos","year":"2008","journal-title":"Chest"},{"issue":"1","key":"2021120900375587400_B46","first-page":"9","article-title":"Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis.","volume":"15","author":"Olagu\u00edbel","year":"2005","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"9","key":"2021120900375587400_B47","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-2222.2011.03835.x","article-title":"Sublingual immunotherapy for allergic conjunctivitis: Cochrane systematic review and meta-analysis.","volume":"41","author":"Calderon","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"2021120900375587400_B48","first-page":"CD002893","article-title":"Sublingual immunotherapy for allergic rhinitis.","author":"Wilson","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2021120900375587400_B49","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/adc.2003.030411","article-title":"Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature.","volume":"89","author":"Sopo","year":"2004","journal-title":"Arch Dis Child"},{"issue":"1","key":"2021120900375587400_B50","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaci.2005.10.010","article-title":"Evaluation of near-fatal reactions to allergen immunotherapy injections.","volume":"117","author":"Amin","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"2021120900375587400_B51","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jaci.2004.02.006","article-title":"Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.","volume":"113","author":"Bernstein","year":"2004","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"2021120900375587400_B52","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1398-9995.2011.02669.x","article-title":"European Academy of Allergy and Clinical Immunology task force report on \u2018dose-response relationship in allergen-specific immunotherapy.\u2019","volume":"66","author":"Calder\u00f3n","year":"2011","journal-title":"Allergy"},{"key":"2021120900375587400_B53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/03946320110240S413","article-title":"Specific immunotherapy in children: the evidence.","volume":"24","author":"La Rosa","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"3","key":"2021120900375587400_B54","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1398-9995.2011.02761.x","article-title":"Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile.","volume":"67","author":"Calder\u00f3n","year":"2012","journal-title":"Allergy"},{"issue":"3","key":"2021120900375587400_B55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.iac.2011.05.001","article-title":"Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.","volume":"31","author":"Cox","year":"2011","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/131\/6\/1155\/897454\/peds_2013-0343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/131\/6\/1155\/897454\/peds_2013-0343.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T06:45:30Z","timestamp":1639032330000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/131\/6\/1155\/31058\/Allergen-Specific-Immunotherapy-for-Pediatric"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2013,6,1]]},"published-print":{"date-parts":[[2013,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2013-0343","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,1]]}}}